Group 7 Copy 3 Created with Sketch.
News Issue Archive Device Guide Calendar Subscribe Advertising

MENU

Centers

Carotid Coding Dialysis Embolization EVAR HTN Limb Salvage Neurointervention Oncology Radial Regulatory Renal SFA TEVAR Venous

News Current Issue Archive Device Guide Calendar Subscribe Advertising About Contact Privacy Submissions
Carotid Coding Dialysis Embolization EVAR HTN Limb Salvage Neurointervention Oncology Radial Regulatory Renal SFA TEVAR Venous

Advertisement

Advertisement

Search Results

Show Filters

close Created with Sketch.

Refine by Content Type

close Created with Sketch.

Refine by Year

close Created with Sketch.

Advertisement

Sort By:

Relevance Date

Choose Sites to Search:

EVToday EVToday + CIToday

evt | Article | November 2016

The Current State of Branched Stent Grafts for the Aortic Arch

A review of five devices with investigational device exemptions in the United States.

By Kira N. Long, MD, and Ross Milner, MD, FACS

evt | Article | November 2016

Practical Thoracic Decision Making

By Edward Y. Woo, MD, and Ian M. Loftus, MD, FRCS

Sponsored by Inari Medical

evt | Article | March 2019

Improving the Risk/Benefit Profile for Managing VTE With Lytic-Free Mechanical Thrombectomy

Drs. Glenn Hoots and Kiran Venkat Chunduri share their experience with the FlowTriever and ClotTriever Systems, respectively, and Drs. Mike Jolly and Nathan Saucier describe the evolution of their venous thromboembolism practices.

With Glenn Hoots, MD, DABR; Mike Jolly, MD; Nathan Saucier, MD; and Kiran Venkat Chunduri, MD

evt | Article | January 2022

Improving Access to UFE: What Are the Barriers?

Increasing awareness of a minimally invasive option to treat uterine fibroids.

By Claire S. Kaufman, MD

Advertisement

Advertisement

evt | Article | January 2023

Team Approaches to Hypertension Management: New Opportunities for Interventionalists

A multidisciplinary approach to hypertension is necessary to achieve optimal outcomes, with interventionalists increasingly involved with the reemergence of promising nonpharmacologic options such as renal denervation.

By Klevin Roger L. Reyes, MD; Gizem Bilgili, MD; and Florian Rader, MD, MSc

evt | Article | July 2016

Ten Lessons Learned in Iliac Venous Stenting

By Seshadri Raju, MD, FACS

evt | Article | July 2019

Surveying the 2019 Venous Stent Landscape

A look at the existing and emerging stents being used to treat venous obstruction.

By Erin H. Murphy, MD, FACS

evt | Article | June 2012

A Look at Proximal Subclavian Artery Occlusive Disease

A review of treatment options.

By Sira Duson, MD, and Seyed-Mojtaba Gashti, DO

evt | News | October 27, 2019

Endologix Responds to FDA Safety Communication on Risk of Type III Endoleaks in AFX EVAR Grafts

October 28, 2019—The FDA announced that it is evaluating new information on the risk of type III endoleak with the AFX endovascular grafts (AFX with Strata, AFX with Duraply, AFX2 [Endologix]) for the treatment of abdominal aortic aneurysms (AAAs).

evt | Article | February 2012

Renal Artery Denervation:
A Brave New Frontier

Emerging therapies for treating patients with severe, treatment-resistant hypertension.
Compiled by Krishna J. Rocha-Singh, MD, FACC, FAHA, FSCAI, FSVM


1

Advertisement

Advertisement

Carotid Coding Dialysis Embolization EVAR HTN Limb Salvage Neurointervention Oncology Radial Regulatory Renal SFA TEVAR Venous
Centers

Carotid Coding Dialysis Embolization EVAR HTN Limb Salvage Neurointervention Oncology Radial Regulatory Renal SFA TEVAR Venous

News• Current Issue• Archive• Device Guide• Advertising• About Calendar• Contact• Privacy• Submissions• Subscriptions


Endovascular Today (ISSN 1551-1944 print and ISSN 2689-792X online) is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field.



magazine Created with Sketch.

Free Print Subscriptions

Fill 1 Created with Sketch.

Email Newsletter



twitter-icon LinkedIn Created with Sketch. instagram BlueSky-Circle
Cardiac Interventions Today
Group 7 Copy 3 Created with Sketch.
bmc-secondary-mark-color copy Created with Sketch.

© 2026 Bryn Mawr Communications II, LLC.  
All Rights Reserved   •   Privacy Policy

one-trust-button